Treatment Outcomes of Esophageal Cancer in Malawi: An Analysis of Overall Survival and Patient-Reported Outcomes
ESCC remains a highly fatal malignancy in Malawi. Most patients at KCH are treated with SEMS or supportive care. Although data must be interpreted with caution given likely confounding, chemotherapy was associated with the highest 12-month survival rate as compared with SEMS and supportive care, whereas SEMS was associated with the highest likelihood of improved dysphagia.
Authors
- Katherine Van Loon (ORCID: https://orcid.org/0000-0002-9705-4114)
- Brittney M. Williams (ORCID: https://orcid.org/0000-0002-1543-6195)
- Gift Mulima (ORCID: https://orcid.org/0000-0001-8367-0779)
- Alan Paciorek (ORCID: https://orcid.org/0000-0003-3900-882X)
- Anthony Charles (ORCID: https://orcid.org/0000-0001-7332-4354)
- Ande Salima
- Bongani Kaimila (ORCID: https://orcid.org/0000-0002-9501-7125)
- Kate D. Westmoreland (ORCID: https://orcid.org/0000-0001-6509-7382)
- Gita N. Mody (ORCID: https://orcid.org/0000-0003-0218-6948)
- Geoffrey Buckle (ORCID: https://orcid.org/0000-0001-7721-0397)
- Li Zhang (ORCID: https://orcid.org/0000-0002-3617-2627)
Institutions
- University of North Carolina at Chapel Hill (US)
- University of California, San Francisco (US)
- Kamuzu Central Hospital (MW)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1200/go-25-00221
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00